References
- Fang W, Yang P. Vogt–Koyanagi–Harada syndrome. Curr Eye Res 2008;33:517–23.
- Abad S, Monnet D, Caillat-Zucman S, Mrejen S, Blanche P, Chalumeau, . Characteristics of Vogt–Koyanagi–Harada disease in a French cohort: ethnicity, systemic manifestations, and HLA genotype data. Ocul Immunol Inflamm 2008;16:3–8.
- Bordaberry MF. Vogt–Koyanagi–Harada disease: diagnosis and treatments update. Curr Opin Ophthalmol 2010;21: 430–5.
- Read RW, Holland GN, Rao NA, Tabbara KF, Ohno S, Arellanes-Garcia L, . Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: report of an international committee on nomenclature. Am J Ophthalmol 2001;13: 647–52.
- Yang P, Ren Y, Li B, Fang W, Meng Q, Kijlstra A. Clinical characteristics of Vogt–Koyanagi–Harada syndrome in Chinese patients. Ophthalmology 2007;114:606–14.
- Tsai JH, Sukavatcharin S, Rao NA. Utility of lumbar puncture in diagnosis of Vogt–Koyanagi–Harada disease. Int Ophthalmol 2007;27:189–94.
- Miyanaga M, Kawaguchi T, Shimizu K, Miyata K, Mochizuki M. Influence of early cerebrospinal fluid-guided diagnosis and early high-dose corticosteroid therapy on ocular outcomes of Vogt–Koyanagi–Harada disease. Int Ophthalmol 2007;27:183–8.
- da Silva FT, Damico FM, Marin ML, Goldberg MC, Hirata CE, Takiuti PH, . Revised diagnostic criteria for Vogt–Koyanagi–Harada disease: considerations on the different disease categories. Am J Ophthalmol 2009;147: 339–45.
- Lai TY, Chan RP, Chan CK, Lam DS. Effects of the duration of initial oral corticosteroid treatment on the recurrence of inflammation in Vogt–Koyanagi–Harada disease. Eye (Lond) 2009;23:543–8.
- Chee SP, Jap A, Bacsal K. Prognostic factors of Vogt–Koyanagi–Harada disease in Singapore. Am J Ophthalmol 2009;147:154–61.